3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Sarcoma
1
Myeloid
1
Conditions
Sarcoma
10
Melanoma
5
Central Nervous System Neoplasms
5
Gliosarcoma
4
Glioblastoma
4
Neoplasm Metastasis
3
Osteosarcoma
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Chondrosarcoma
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thymoma
1
Sezary Syndrome
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pain
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Interventions
Temozolomide
14
Filgrastim
13
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
Carboplatin
7
Peripheral Blood Stem Cell Transplantation
6
Irinotecan
6
Granulocyte Colony-Stimulating Factor
6
Etoposide
6
X-Rays
5
Topotecan
5
Thiotepa
5
Phantoms, Imaging
5
Busulfan
5
Biopsy
5
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Ifosfamide
4
sargramostim
3
palbociclib
3
olaparib
3
etoposide phosphate
3
Surgical Procedures, Operative
3
Paclitaxel
3
ulixertinib
2
trioctyl phosphine oxide
2
tipifarnib
2
tazemetostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Celecoxib
×
Sarcoma
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled